PRESS INQUIRIES

Mapp Biopharmaceutical, Inc.

We develop novel pharmaceuticals for the prevention and treatment of infectious diseases, focusing on unmet needs in global health and biodefense.

Mapp Bio
Leaf Bio

In the News

Mapp Bio Press Release
MappBio Announces Contracts with BARDA for ZMappTM and Additional Filovirus Medical Countermeasures

September 29, 2017

antibody
Researchers Discover First Human Antibodies That Work Against All Ebolaviruses

May 19, 2017

antibody
Researchers develop Marburg virus treatment effective five days after infection

April 5, 2017

PBS Newshour

PBS NewsHour – How to grow an Ebola vaccine with a tobacco plant
November 23, 2015

Publications

Mapp Bio Publications

Therapeutic treatment of Marburg and Ravn virus infection in nonhuman primates with a human monoclonal antibody.
Apr 05, 2017

Antibodies from a Human Survivor Define Sites of Vulnerability for Broad Protection against Ebolaviruses,.
Apr, 2017

De Novo MS/MS Sequencing of Native Human Antibodies.
Oct 25, 2016

A Randomized, Controlled Trial of ZMapp for Ebola Virus Infection.
Oct 13, 2016

Monoclonal antibody therapy for Junin virus infection.
Apr 4, 2016

Antibody therapeutics for Ebola virus disease.
January 27, 2016

READ MORE

© 2017 Mapp Biopharmaceautical - Leaf Bio. All Rights Reserved.